The blood cancer drug, acalabrutinib, was found to diminish respiratory distress and reduced hyperactive immune response known as 'cytokine storms' in coronavirus patients
According to the research, a protein known as TiPARP, suppresses a transcription factor, HIF-1, that plays a crucial role in several kinds of cancers including breast cancer